Likewise, Kubo et al. reported a statistically significant higher prevalence of positivity for anti-MDA-5 autoantibodies and anti-TIF-1γ autoantibodies in patients with NVC scleroderma spectrum abnormalities relative to those without NVC scleroderma spectrum abnormalities [10]. This evidence concerns the gene TRIM33 and scleroderma.